|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Stage IV Colon Cancer | |||||
| Recurrent Colon Cancer | |||||
| Adenocarcinoma of the Colon | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Adenocarcinoma | |||||
| Colonic Neoplasms | |||||
| 3 | More general conditions related to this trial | ||||
| Carcinoma | |||||
| Colonic Diseases | |||||
| Colorectal Neoplasms | |||||
| Digestive System Diseases | |||||
| Digestive System Neoplasms | |||||
| Gastrointestinal Diseases | |||||
| Gastrointestinal Neoplasms | |||||
| Intestinal Diseases | |||||
| Intestinal Neoplasms | |||||
| Neoplasms | |||||
| Neoplasms by Histologic Type | |||||
| Neoplasms by Site | |||||
| Neoplasms, Glandular and Epithelial | |||||
| 4 | Interventions listed in this trial | ||||
| antineoplaston A10 | |||||
| antineoplaston AS2-1 | |||||
| alternative product therapy | |||||
| biological therapy | |||||
| biologically based therapies | |||||
| cancer prevention intervention | |||||
| differentiation therapy | |||||
| 5 | Sponsors listed in this trial | ||||
| Burzynski Research Institute | |||||